CNS & Neurological Disorders - Drug Targets
Title:COMMENTARY: Magnetic Resonance Techniques Applied to Parkinson’s Disease
Volume: 16 Issue: 2
Author(s): Benito de Celis Alonso, Silvia S. Hidalgo-Tobón, Andrea Herrera-Solís and Oscar Arias-Carrión
Affiliation:
Export Options
About this article
Cite this article as:
Alonso de Celis Benito, Hidalgo-Tobón S. Silvia, Herrera-Solís Andrea and Arias-Carrión Oscar, COMMENTARY: Magnetic Resonance Techniques Applied to Parkinson’s Disease, CNS & Neurological Disorders - Drug Targets 2017; 16 (2) . https://dx.doi.org/10.2174/1871527316666170117164253
DOI https://dx.doi.org/10.2174/1871527316666170117164253 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Chemokines and Persistent Inflammation in Rheumatoid Arthritis: Hunting for Therapeutic Targets
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents The CRF Receptor Structure, Function and Potential for Therapeutic Intervention.
Current Medicinal Chemistry - Central Nervous System Agents Biomarkers of Cell Damage Induced by Oxidative Stress in Parkinsons Disease and Related Models
Central Nervous System Agents in Medicinal Chemistry TRPC Channels and their Implications for Neurological Diseases
CNS & Neurological Disorders - Drug Targets Leveraging Structural Diversity and Allosteric Regulatory Mechanisms of Protein Kinases in the Discovery of Small Molecule Inhibitors
Current Medicinal Chemistry Neurotrophic Factors for the Investigation and Treatment of Movement Disorders
Current Medicinal Chemistry - Central Nervous System Agents Fiber-Optic Technologies in Laser-Based Therapeutics: Threads for a Cure
Current Pharmaceutical Biotechnology Aurora-B Kinase Inhibitors for Cancer Chemotherapy
Mini-Reviews in Medicinal Chemistry Pyruvate Dehydrogenase Kinases in the Nervous System: Their Principal Functions in Neuronal-glial Metabolic Interaction and Neuro-metabolic Disorders
Current Neuropharmacology Glycine/NMDA Receptor Antagonists as Potential CNS Therapeutic Agents: ACEA-1021 and Related Compounds
Current Topics in Medicinal Chemistry Layer Protecting the Surface of Zirconium Used in Nuclear Reactors
Recent Patents on Nanotechnology Nuclear Architecture and Gene Expression in the Quest for Novel Therapeutics
Current Pharmaceutical Design Genetics of Primary CoQ10 Deficiency
Current Genomics Oxidative Stress and Antioxidants in Neurological Diseases: Is There Still Hope?
Current Drug Targets Tauopathies – Focus on Changes at the Neurovascular Unit
Current Alzheimer Research Editorial [Hot topic: Psychotropic Drugs in Child and Adolescent Psychiatry - a New Era on the Horizon (Executive Editors: Aribert Rothenberger, Manfred Gerlach and Ralf W. Dittmann)]
Current Pharmaceutical Design Age-Related Sleep Changes and its Implication in Neurodegenerative Diseases
Current Aging Science Advances in Neuroimaging for HIV-1 Associated Neurological Dysfunction: Clues to the Diagnosis, Pathogenesis and Therapeutic Monitoring
Current HIV Research Bioactivity of Hybrid Polymeric Magnetic Nanoparticles and Their Applications in Drug Delivery
Current Pharmaceutical Design Progress in the Development of Melanocortin Receptor Selective Ligands
Current Pharmaceutical Design